Article Details
Retrieved on: 2025-03-15 04:58:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease. Published on: Friday, ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here